Lack of EGF receptor contributes to drug sensitivity of human germline cells

S. J. Park, S. Armstrong, C. H. Kim, M. Yu, Kent Robertson, Mark Kelley, Suk-Hee Lee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Germline mutations have been associated with generation of various types of tumour. In this study, we investigated genetic alteration of germline tumours that affect the drug sensitivity of cells. Although all germline tumour cells we tested were hypersensitive to DNA-damaging drugs, no significant alteration was observed in their DNA repair activity or the expression of DNA repair proteins. In contrast, germline tumours expressed very low level of epidermal growth factor receptor (EGFR) compared to drug-resistant ovarian cancer cells. An immunohistochemical analysis indicated that most of the primary germline tumours we tested expressed very low level of EGFR. In accordance with this, overexpression of EGFR in germline tumour cells showed an increase in drug resistance, suggesting that a lack of EGFR, at least in part, contributes to the drug sensitivity of germline tumours.

Original languageEnglish
Pages (from-to)334-341
Number of pages8
JournalBritish Journal of Cancer
Volume92
Issue number2
DOIs
StatePublished - Jan 31 2005

Fingerprint

Epidermal Growth Factor Receptor
Pharmaceutical Preparations
Neoplasms
DNA Repair
Germ-Line Mutation
Drug Resistance
Ovarian Neoplasms
DNA
Proteins

Keywords

  • Cancer chemotherapy
  • Cisplatin
  • DNA damage
  • Drug resistance
  • Epidermal growth factor receptor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lack of EGF receptor contributes to drug sensitivity of human germline cells. / Park, S. J.; Armstrong, S.; Kim, C. H.; Yu, M.; Robertson, Kent; Kelley, Mark; Lee, Suk-Hee.

In: British Journal of Cancer, Vol. 92, No. 2, 31.01.2005, p. 334-341.

Research output: Contribution to journalArticle

Park, S. J. ; Armstrong, S. ; Kim, C. H. ; Yu, M. ; Robertson, Kent ; Kelley, Mark ; Lee, Suk-Hee. / Lack of EGF receptor contributes to drug sensitivity of human germline cells. In: British Journal of Cancer. 2005 ; Vol. 92, No. 2. pp. 334-341.
@article{9b8755a6d24c48788359e0ca113adaf2,
title = "Lack of EGF receptor contributes to drug sensitivity of human germline cells",
abstract = "Germline mutations have been associated with generation of various types of tumour. In this study, we investigated genetic alteration of germline tumours that affect the drug sensitivity of cells. Although all germline tumour cells we tested were hypersensitive to DNA-damaging drugs, no significant alteration was observed in their DNA repair activity or the expression of DNA repair proteins. In contrast, germline tumours expressed very low level of epidermal growth factor receptor (EGFR) compared to drug-resistant ovarian cancer cells. An immunohistochemical analysis indicated that most of the primary germline tumours we tested expressed very low level of EGFR. In accordance with this, overexpression of EGFR in germline tumour cells showed an increase in drug resistance, suggesting that a lack of EGFR, at least in part, contributes to the drug sensitivity of germline tumours.",
keywords = "Cancer chemotherapy, Cisplatin, DNA damage, Drug resistance, Epidermal growth factor receptor",
author = "Park, {S. J.} and S. Armstrong and Kim, {C. H.} and M. Yu and Kent Robertson and Mark Kelley and Suk-Hee Lee",
year = "2005",
month = "1",
day = "31",
doi = "10.1038/sj.bjc.6602315",
language = "English",
volume = "92",
pages = "334--341",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Lack of EGF receptor contributes to drug sensitivity of human germline cells

AU - Park, S. J.

AU - Armstrong, S.

AU - Kim, C. H.

AU - Yu, M.

AU - Robertson, Kent

AU - Kelley, Mark

AU - Lee, Suk-Hee

PY - 2005/1/31

Y1 - 2005/1/31

N2 - Germline mutations have been associated with generation of various types of tumour. In this study, we investigated genetic alteration of germline tumours that affect the drug sensitivity of cells. Although all germline tumour cells we tested were hypersensitive to DNA-damaging drugs, no significant alteration was observed in their DNA repair activity or the expression of DNA repair proteins. In contrast, germline tumours expressed very low level of epidermal growth factor receptor (EGFR) compared to drug-resistant ovarian cancer cells. An immunohistochemical analysis indicated that most of the primary germline tumours we tested expressed very low level of EGFR. In accordance with this, overexpression of EGFR in germline tumour cells showed an increase in drug resistance, suggesting that a lack of EGFR, at least in part, contributes to the drug sensitivity of germline tumours.

AB - Germline mutations have been associated with generation of various types of tumour. In this study, we investigated genetic alteration of germline tumours that affect the drug sensitivity of cells. Although all germline tumour cells we tested were hypersensitive to DNA-damaging drugs, no significant alteration was observed in their DNA repair activity or the expression of DNA repair proteins. In contrast, germline tumours expressed very low level of epidermal growth factor receptor (EGFR) compared to drug-resistant ovarian cancer cells. An immunohistochemical analysis indicated that most of the primary germline tumours we tested expressed very low level of EGFR. In accordance with this, overexpression of EGFR in germline tumour cells showed an increase in drug resistance, suggesting that a lack of EGFR, at least in part, contributes to the drug sensitivity of germline tumours.

KW - Cancer chemotherapy

KW - Cisplatin

KW - DNA damage

KW - Drug resistance

KW - Epidermal growth factor receptor

UR - http://www.scopus.com/inward/record.url?scp=14844338449&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14844338449&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6602315

DO - 10.1038/sj.bjc.6602315

M3 - Article

C2 - 15655552

AN - SCOPUS:14844338449

VL - 92

SP - 334

EP - 341

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 2

ER -